STAT+: Glenmark to pay $29.6 million to settle price-fixing allegations in long-running battle with states
AI Summary
Glenmark Pharmaceuticals agreed to pay $29.6 million to settle allegations of price-fixing after a protracted legal battle with multiple U.S. states. The settlement resolves accusations related to pharmaceutical pricing practices.
Glenmark Pharmaceuticals agreed to pay $29.6 million to settle price-fixing allegations in a long-running battle with dozens of states.